Search Results Page

Syngene Intnal hits a record high

about 10 years ago

Syngene International announced yesterday after market hours that it has completed a deal through which Syngene has purchased assets of Strand Life Sciences related to systems biology, Heptox and pharma bioinformatics services. This includes target dossier business and rights to NGS data analytic ...

Syngene up over 5%

about 4 years ago

The stock is doing pretty well today morning, rising over 5% to an intraday high at Rs.616.90 on the back of an over 6x times in volumes. Its 52-week high is at Rs.699.95.

Biocon jumps on Syngene DRHP

about 12 years ago

Biocon is seeing some activity on its counter today. The stock, which has been lying low for some time now, is currently up 1.5% at Rs.463, with an intra day high at Rs.470.45. The company has filed a Draft red Herring Prospectus (DRHP) today morning for its wholly owned subsidiary, Syngene, ...

Syngene International up 9%

about 6 years ago

Rising for the past two days, the stock continued to rise today too. It opened almost 3.5% higher and went up further by 9% to Rs.494.15.

Syngene

about 11 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Syngene down in the red

about 2 years ago

Following this, the stock is down in the red, top loser on the BSE and currently down 12.5% at Rs.656 levels. Its 52-week low is at Rs.608.

Syngene Intnal hits a new high

about 10 years ago

Syngene International hit a new 52-week high today at Rs.510 and despite coming off this high, it remains firmly in the green, up over 5%. This sudden new found love for the stock is on good news that the company’s new R&D facility for Amgen Inc, in Bangalore has finally been commi ...

Biocon in the green

about 13 years ago

Biocon is doing pretty well today, with the stock opening higher at Rs.444, going on to hit an intra day high at Rs.457.50 and currently hovers around the same levels. The stock is seeing activity today on the back of its announcement yesterday – the company’s subsidiary, Syngene ...

Biocon jumps up on good Q4

about 12 years ago

Biocon posted a strong performance for Q4FY15 despite the exceptional income of Rs.105 crore via sale of shares in Syngene, its R&D arm. Consolidated net profit showed a jump of a whopping 122% at Rs.201 crore. And PBT before exceptional income rose 32% at Rs.143 crore. Overall it has be ...

Biocon hits a life time new high

about 10 years ago

The market is most obviously trilled to bits with the performance of Biocon. The company for Q1FY17 posted a 34% (YoY) jump in consolidated net profit at Rs.167 crore on a 21% jump in total revenue at Rs.982 crore. This performance was driven mainly by a strong uptick in two of its segments & ...

Biocon up 3% on strong Q1

about 11 years ago

Shares of Asia’s premier biopharmaceutical company Biocon Limited are up close to 3% at Rs. 471.60, a piece, with healthy volumes on both the exchanges. While being debt-free, company’s market cap exceeds Rs. 9,400 crore currently. The company, led by Dr. Kiran Mazumdar ...

IPO MARKETS - THAT'S WHERE ALL THE ACTION IS!

about 11 years ago

While the secondary market is looking lackluster, hunting around for a trigger, the primary market is seeing some blockbuster action. Take a look at this statistics. In 2014, there were 6 IPOs and they managed to collect Rs.1261 crore. Prior to that, in 2013, there were just 3 IPOs and they garnered Rs.1284 crore.

Biocon tanks on disappointing Q3

about 12 years ago

Biocon fell today morning after it declared its Q3FY15 performance. From yesterday’s close of Rs.426.15, it opened lower at Rs.421.50 and went down to the days low at Rs.411, a decline of 3.5%. The company posted a 13% (YoY) dip in net profit for the quarter at Rs.91 crore though reven ...

Biocon shines 'silver'

about 12 years ago

Biocon is a big star today on Dalal Street. The stock opened higher by around Rs.11 at Rs.510.35 and went on to an intra day high at Rs.514.90 and currently trades at Rs.512 levels. The stock is up after the company stated that Silver Leaf Oak (Mauritius) is picking up a 10% ...

Anthem Biosciences

about 1 year ago

A ‘Blockbuster’
Subscription Start Date :14 Jul 2025 End Date :16 Jul 2025
Issue Size : Rs. 3,395 cr, Issue Type : OFS
Price Band : Rs.540 to Rs. 570
--------------------------------------------------
Overall Subscription : 63.86x
QIB : 182.65x,HNI :42.36x,Retail :5.64x,Other :6.6x
Listing Date : 21 Jul 2025, , Listing Price : 723

Gland Pharma

about 6 years ago

Verdict :Growth and Margins justify Pricing
Subscription Start Date :9 Nov 2020 End Date :11 Nov 2020
Issue Size : 6480 crore, Issue Type : Fresh cum OFS
Price Band : Rs.1490 to Rs. 1500
--------------------------------------------------
Overall Subscription : 2.06x
QIB : 6.4x,HNI :0.51x,Retail :0.24x
Listing Date : 20 Nov 2020, , Listing Price : 1710

Biocon posts super numbers

about 7 years ago

The markets have reacted positively but not exactly ecstatically, opening 5% higher at Rs.250.50 and hitting an intraday high at Rs.252, up 5.6%.